HKEX:6978 stock news
This page provides real-time market news, earnings updates, and company announcements related to Immunotech Biopharm Ltd (HKEX:6978).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-27 22:30 HKT
CORRECTION: AIM ImmunoTech Announces Commencement of Rights Offering
Finviz2026-02-12 21:39:08
AIM ImmunoTech Announces Planned Milestones in the Ongoing Phase 2 Trial of Ampligen and AstraZeneca's Durvalumab in the Treatment of Metastatic Pancreatic Cancer
Finviz2026-02-23 13:57:57
AIM ImmunoTech Announces Extension of Subscription Period of its Previously Announced Rights Offering to March 3, 2026
Finviz2026-02-25 14:03:11
AIM ImmunoTech Inc. recently announced that it will extend the exercise period for shareholder subscription rights in its previously announced stock offering plan.
老虎证券2026-02-25 14:25:16
HKEX:6978 stock price change
On the last trading day, HKEX:6978 stock closed at 2.72 HKD, with a price change of -0.37% for the day.
Trade stock perpsHKEX:6978 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more